Buy Smart Drugs Nootropics Powder Idra-21 (CAS: 22503-72-6) for Brain Improve
What is IDRA-21?
IDRA-21 is a relatively new nootropic compound. It works as an ampakine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits.
IDRA-21 Basic Information
| Chemical name |
IDRA-21 |
| CAS No. |
22503-72-6 |
| Supplier |
Lyphar Biotech |
| Molecular Formula |
C8H9ClN2O2S |
| Other name |
(3R)-7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide |
| Store at |
Room temperature |
| Purity |
99% min |
| Appearance |
White to off white powder |
IDRA-21 Certificate of Analysis
| Product name |
IDRA-21 |
| CAS No. |
22503-72-6 |
Outer Packing |
1KG/bag |
| Production date |
15th Jan 2018 |
Shelf life |
14th Jan 2020 |
| Standard adopted |
Enterprise standard |
| Analysis Test |
Specification |
Result |
| Description |
White to off white powders |
Complies |
| Identification |
IR: The infra red absorption spectrum of the sample should be similar to the IR absorption spectrum of IDRA-21 working standard. |
Complies |
| Assay |
≥99.0% |
99.57% |
| Solution clarity and color |
solution should be clear and colorless |
Conforms |
| Loss on drying |
≤0.5% |
0.11% |
| Residue on ignition |
≤0.1% |
0.04% |
| Heavy mentals |
≤20ppm |
≤ |
| Chromatographic purity (HPLC) |
Max single impurity: ≤0.5%
Total impurities: ≤1.0% |
0.02%
0.07% |
| Conclusion: The results conform with CP2010 |
IDRA-21 Benefits
- Increases in cognition (Matching sample tasks performed by Rhesus Monkeys)
- Increased Task Accuracy
- Increases in Short Term Memory
- Potential Therapeutic Effects On Schizophrenie
- Potental Therapeutic Effects On Depression
- Neuroprotection
- Benefits Against Alprazolam-induced Cognitive Deficit
IDRA-21 Dosage
IDRA-21 currently has only had animal trials. Dosing in a study with Patas Monkeys was 3 or 5.6 mg/kg p.o. in addition with 30 mg/kg p.o. of Aniracetam. This study indicated that IDRA-21 was 10-fold more potent than Aniracetam at reducing learning defects. A water maze study in rats showed cognitive enhancement at oral dosages of 4-120 mumol/kg.
Human dosages have no history of peer-reviewed clinical studies. Some reading online suggested positive human activity at 5-25mg orally.
IDRA-21 Side Effects
IDRA-21 is a potent Ampakine. AMPA activation has been shown to exacerbate hippocampal neural damage. IDRA-21 when administered with glutamate killed rat hippocampal neurons through AMPA excitoxicity. This is potentially dangerous in patients with conditions that excessively activate AMPA such as strokes and seizures.
